• 1
    Robertson AJ, Anderson JM, Beck JS, Burnett RA, Howatson SR, Lee FD, Lessells AM, McLaren KM, Moss SM, Simpson JG. Observer variability in histopathological reporting of cervical biopsy specimens. J Clin Pathol 1989; 42: 2318.
  • 2
    Stoler MH, Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL triage study. JAMA 2001; 285: 15005.
  • 3
    Ismail SM, Colelough AB, Dinnen JS, Eakins D, Evans DM, Gradwell E, O'Sullivan JP, Summerell JM, Newcombe RG. Observer variation in histopathological diagnosis and grading of cervical intraepithelial neoplasia. BMJ 1989; 298: 70710.
  • 4
    McCluggage WG, Walsh MY, Thornton CM, Hamilton PW, Date A, Caughley LM, Bharucha H. Inter- and intra-observer variation in the histopathological reporting of cervical squamous intraepithelial lesions using a modified Bethesda grading system. Br J Obstet Gynaecol 1998; 105: 20610.
  • 5
    Chen Y, Miller C, Mosher R, Zhao X, Deeds J, Morrissey M, Bryant B, Yang D, Meyer R, Cronin F, Gostout BS, Smith-McCune K, et al. Identification of cervical cancer markers by cDNA and tissue microarrays. Cancer Res 2003; 63: 192735.
  • 6
    von Knebel Doeberitz M. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer 2002; 38: 222942.
  • 7
    Keating JT, Cviko A, Riethdorf S, Riethdorf L, Quade BJ, Sun D, Duensing S, Sheets EE, Munger K, Crum CP. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 2001; 25: 88491.
  • 8
    Cho NH, Kim YT, Kim JW. Alteration of cell cycle in cervical tumor associated with human papillomavirus: cyclin-dependent kinase inhibitors. Yonsei Med J 2002; 43: 7228.
  • 9
    Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 1998; 153: 17418.
  • 10
    Park TW, Riethdorf S, Schulz G, Riethdorf L, Wright T, Loning T. Clonal expansion and HPV-induced immortalization are early molecular alterations in cervical carcinogenesis. Anticancer Res 2003; 23: 15560.
  • 11
    Kruse AJ, Baak JP, Janssen EA, Bol MG, Kjellevold KH, Fianne B, Lovslett K, Bergh J. Low- and high-risk CIN 1 and 2 lesions: prospective predictive value of grade, HPV, and Ki-67 immuno-quantitative variables. J Pathol 2003; 199: 46270.
  • 12
    Alazawi WO, Morris LS, Stanley MA, Garrod DR, Coleman N. Altered expression of desmosomal components in high-grade squamous intraepithelial lesions of the cervix. Virchows Arch 2003; 443: 516.
  • 13
    Wang PH, Chang H, Ko JL, Lin LY. Nm23-H1 immunohistochemical expression in multisteps of cervical carcinogenesis. Int J Gynecol Cancer 2003; 13: 32530.
  • 14
    Chil A, Sikorski M, Bobek M, Jakiel G, Marcinkiewicz J. Alterations in the expression of selected MHC antigens in premalignant lesions and squamous carcinomas of the uterine cervix. Acta Obstet Gynecol Scand 2003; 82: 114652.
  • 15
    Bosch FX, de Sanjose S. Chapter 1: Human papillomavirus and cervical cancer—burden and assessment of causality. J Natl Cancer Inst Monogr 2003; 31: 313.
  • 16
    Wang SS, Trunk M, Schiffman M, Herrero R, Sherman ME, Burk RD, Hildesheim A, Bratti MC, Wright T, Rodriguez AC, Chen S, Reichert A, et al. Validation of p16INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a population-based cohort in Costa Rica. Cancer Epidemiol Biomarkers Prev 2004; 13: 135560.
  • 17
    Kalof AN, Evans MF, Simmons-Arnold L, Beatty BG, Cooper K. p16INK4A immunoexpression and HPV in situ hybridization signal patterns: potential markers of high-grade cervical intraepithelial neoplasia. Am J Surg Pathol 2005; 29: 6749.
  • 18
    Agoff SN, Lin P, Morihara J, Mao C, Kiviat NB, Koutsky LA. p16(INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol 2003; 16: 66573.
  • 19
    Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, Dallenbach-Hellweg G, Schmidt D, von Knebel Doeberitz M. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001; 92: 27684.
  • 20
    Negri G, Vittadello F, Romano F, Kasal A, Rivasi F, Girlando S, Mian C, Egarter-Vigl E. p16INK4a expression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri. Virchows Arch 2004; 445: 61620.
  • 21
    Valenstein PN. Evaluating diagnostic tests with imperfect standards. Am J Clin Pathol 1990; 93: 2528.
  • 22
    Franco EL. Statistical issues in human papillomavirus testing and screening. Clin Lab Med 2000; 20: 34567.
  • 23
    Klaes R, Benner A, Friedrich T, Ridder R, Herrington S, Jenkins D, Kurman RJ, Schmidt D, Stoler M, von Knebel Doeberitz M. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2002; 26: 138999.
  • 24
    Denny L, Kuhn L, Pollack A, Wainwright H, Wright TC,Jr. Evaluation of alternative methods of cervical cancer screening for resource-poor settings. Cancer 2000; 89: 82633.
  • 25
    Sankaranarayanan R, Sellors J. Colposcopy and treatment of cervical intraepithelial neoplasia: a beginner's manuel. Lyon, France: IARC, 2003.
  • 26
    Kuhn L, Denny L, Pollack A, Lorincz A, Richart RM, Wright TC. Human papillomavirus DNA testing for cervical cancer screening in low- resource settings. J Natl Cancer Inst 2000; 92: 81825.
  • 27
    Denny L, Kuhn L, Pollack A, Wright TC,Jr. Direct visual inspection for cervical cancer screening: an analysis of factors influencing test performance. Cancer 2002; 94: 1699707.
  • 28
    Shi SR, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991; 39: 7418.
  • 29
    Dray M, Russell P, Dalrymple C, Wallman N, Angus G, Leong A, Carter J, Cheerala B. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I. Experience with squamous lesions in 189 consecutive cervical biopsies. Pathology 2005; 37: 11224.
  • 30
    Valenstein PN, Emancipator K. Sensitivity, specificity, and reproducibility of four measures of laboratory turnaround time. Am J Clin Pathol 1989; 91: 4527.
  • 31
    Singer A, Monaghan JM. Lower genital tract precancer: colposcopy, pathology and treatment. London: Blackwell, 1994.